Basic Information
| LncRNA/CircRNA Name | AK001058 |
| Synonyms | NA |
| Region | GRCh38_5:33523536-33525166 |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | plasma, gastric cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Five lncRNAs, including AK001058, INHBA-AS1, MIR4435-2HG, UCA1 and CEBPA-AS1 were validated to be increased in gastric cancer tissues. Furthermore, we found that plasma level of these five lncRNAs were significantly higher in gastric cancer patients compared with normal controls. |
| Pubmed ID | 28423525 |
| Year | 2017 |
| Title | The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer |
External Links
| Links for AK001058 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |